This inventor holds 1 USPTO granted patent. Top assignee: Vivus, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Thomas Najaraian: Innovator in Weight Loss Solutions
Introduction
Thomas Najaraian is a notable inventor based in Los Osos, California. He has made significant contributions to the field of weight loss through his innovative patent. His work focuses on the combination of medications to enhance effectiveness in treating obesity.
Latest Patents
Najaraian holds a patent for a "Low dose topiramate/phentermine composition and methods of use thereof." This patent describes a method for effecting weight loss by administering a combination of topiramate and phentermine. The phentermine is generally administered in immediate release form, with a daily dose ranging from 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. The patent also includes methods for treating obesity and conditions associated with obesity, as well as compositions and dosage forms containing low doses of phentermine and topiramate, such as 3.75 mg phentermine and 23 mg topiramate.
Career Highlights
Najaraian is associated with Vivus, Inc., a company dedicated to developing innovative therapeutic solutions. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of weight management.
Collaborations
Some of his notable coworkers include Leland F Wilson and Peter Y Tam, who have also contributed to the development of innovative solutions in their respective fields.
Conclusion
Thomas Najaraian's contributions to weight loss solutions through his patent demonstrate his commitment to improving health outcomes. His innovative approach continues to influence the pharmaceutical landscape.